WaveMan
WaveMan · Company
CHR · Cheer Holding, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

CHR Cheer (CHR) Insider Trading, Ownership & Congress Trades

Software & IT · Services-computer processing & data preparation · CIK 0001738758
Activist 13D
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

What the filings say about CHR

Activist stakes (13D), 180 days
1 filing
Largest: 100.0% of the class

Cheer insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Cheer Holding, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-27.

Foreign private issuer: its insiders are exempt from SEC Form 4 and report in the home market, so their buys and sells do not appear here.

Insider
Filed
Shares
Value
Since filing

no insider purchases or sales on record

0 transactions on record
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+1.1% year over year
below 68% of Software & IT
Margin
17.2% net margin
more than 82% of Software & IT
Buybacks
no share repurchases reported
Short interest
4.0% of the float short (float per yahoo 2026-10-26) · 1.5 days to cover · settled 2026-09-30
below 70% of Software & IT
The situation: each line is one rule over one dataset
Lioness Ltd disclosed a 5%+ stake (100.0%) in the last six months.
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch CHR

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

Who owns CHR: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in CHR

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

13D: intends to influence · 13G: passive
Lioness Ltd
Activist 13D · 2026-09-23
100.0%
Lim Kien Leong
Activist 13D · 2026-09-23
100.0%

CHR planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Same sector, ranked by filing activity
Sector by SEC SIC code

CHR financials

Revenue growth
+1.1%
XBRL, annual
Net margin
17.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
0.02x
long-term 2023-12-31 plus current 2025-12-31; equity 2025-12-31
Cash flow to debt
2.84x
TTM operating cash flow over long-term 2023-12-31 plus current 2025-12-31
Return on equity
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on assets
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
n/a
no close on file at or before the as-of date
FCF yield
n/a
no close on file at or before the as-of date
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$148.8M$147.2M$152.3M$157.1M
Operating income$26.3M$25.6M$29.3M$26.7M
Net income$25.6M$26.0M$30.5M$26.9M
EPS (diluted)24.07125.72150.313.95
Operating cash flow$17.9M$22.9M$42.2M$7.7M
Cash$242.1M$197.7M$194.5Mn/a
Long-term debtn/an/a$1.4Mn/a
SEC XBRL, fiscal years, as known on 2026-10-27

CHR Stock Sonar score 3/7 axes

Find similar shapesCompare

CHR ranks highest on financial health (81st percentile) and risk and compliance (56th), and lowest on growth (32nd), among Software & IT peers.

Financial health
81
Inputs
  • Debt to equity0.02x · 73 pct, sector of 288
  • Cash flow to debt2.84x · 89 pct, sector of 241
Growth
32
Inputs
  • Revenue growth, YoY+1.1% · 32 pct, sector of 480
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
56
Inputs
  • Short interest, % of float+4.0% · 56 pct, sector of 530
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Insider conviction, Institutional and government, US patents
  • Profitability needs 2 of 4 inputs, 0 present: the filed year and its quarters do not reconcile, so the trailing figure is withheld
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

CHR filings, in plain words

Read the full summary

1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 100.0% of the class. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing